⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 8, 2024

[Pituitary Crooke cell neuroendocrine tumor of adrenocorticotropic hormone differentiation-specific transcription factor lineage: a clinicopathological analysis of six cases].

Chen Ge Q Wang W Wang L Q Cheng Y E Wang L L Huang Y J Li H B Wu A L Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the clinicopathological features of Crooke cell tumor of adrenocorticotropic hormone differentiation specific transcription factor (TPIT, also known as transcription factor 19, TBX19) lineage neuroendocrine tumors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ge et al. (2024) studied this question.

synapsesocial.com/papers/68e61080b6db6435875a352c https://doi.org/10.3760/cma.j.cn112151-20231208-00397

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO EraOriginal Research · 2026 · 4 citations
26630 Crooke Cell Pituitary Adenoma Without a Cushingoid Appearance2024
3Pituitary Neuroendocrine Tumor Organoids Generated from Induced Pluripotent Stem Cells Reveal the Dysregulation of Cell Lineage Differentiation in Cushing’s Disease2024
4CNSC-61. NEURAL SIGNATURE DISTINGUISHES SILENT FROM OVERT PHENOTYPE IN CORTICOTROPIC PITNETS2025
5#1707679 A Rare Case of a Gonadotroph Plurihormonal Pituitary Neuroendocrine Tumor2024